Literature DB >> 11143556

Kolmogorov-Smirnov statistic and its application in library design.

D N Rassokhin1, D K Agrafiotis.   

Abstract

After several years of frantic development, the dream of an "ideal" library remains elusive. Traditionally, combinatorial chemistry has been used primarily for lead generation, and molecular diversity has been the method of choice for designing and prioritizing experiments. One aspect that often has been overlooked is the drug likeness of the resulting collections. Recently, there have been several attempts to quantify this concept and incorporate it directly into the design process. This article demonstrates the limitations of some conventional methodologies and proposes a new paradigm for experimental design based on the principles of multiobjective optimization. This method allows traditional design objectives such as diversity or similarity to be combined with secondary selection criteria in order to bias the selection toward more pharmacologically relevant regions of chemical space. The method is robust, general, and easily extensible, and it allows the medicinal chemist to create designs that represent the best compromise between several, often conflicting, objectives. Two types of designs are discussed (singles, arrays), and a novel criterion based on the Kolmogorov-Smirnov statistic is proposed as a means to enforce a particular distribution on key molecular properties that are related to drug likeness. The potential of this approach is illustrated in the design of an exploratory library based on the simultaneous optimization of five different parameters. These parameters are combined in an intuitive manner to produce a design that is sufficiently diverse, exhibits a molecular weight and logP profile that is consistent with the respective distributions of known drugs, requires a small number of reagents, and can be synthesized easily in array format using robotic hardware.

Entities:  

Mesh:

Year:  2000        PMID: 11143556     DOI: 10.1016/s1093-3263(00)00063-2

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  8 in total

1.  Identification and handling of artifactual gene expression profiles emerging in microarray hybridization experiments.

Authors:  Leonid Brodsky; Andrei Leontovich; Michael Shtutman; Elena Feinstein
Journal:  Nucleic Acids Res       Date:  2004-03-03       Impact factor: 16.971

2.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery.

Authors:  Sean Ekins; Bruno Boulanger; Peter W Swaan; Maggie A Z Hupcey
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

3.  Identification of global transcriptional dynamics.

Authors:  Eric H Yang; Richard R Almon; Debra C Dubois; Willian J Jusko; Ioannis P Androulakis
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

Review 4.  Towards a new age of virtual ADME/TOX and multidimensional drug discovery.

Authors:  Sean Ekins; Bruno Boulanger; Peter W Swaan; Maggie A Z Hupcey
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

5.  An unusual ERAD-like complex is targeted to the apicoplast of Plasmodium falciparum.

Authors:  Simone Spork; Jan A Hiss; Katharina Mandel; Maik Sommer; Taco W A Kooij; Trang Chu; Gisbert Schneider; Uwe G Maier; Jude M Przyborski
Journal:  Eukaryot Cell       Date:  2009-06-05

6.  Extracting global system dynamics of corticosteroid genomic effects in rat liver.

Authors:  E Yang; R R Almon; D C Dubois; W J Jusko; I P Androulakis
Journal:  J Pharmacol Exp Ther       Date:  2007-12-17       Impact factor: 4.030

7.  Bioinformatics analysis of the early inflammatory response in a rat thermal injury model.

Authors:  Eric Yang; Timothy Maguire; Martin L Yarmush; Francois Berthiaume; Ioannis P Androulakis
Journal:  BMC Bioinformatics       Date:  2007-01-10       Impact factor: 3.169

8.  Docking Analysis and Multidimensional Hybrid QSAR Model of 1,4-Benzodiazepine-2,5-Diones as HDM2 Antagonists.

Authors:  Yujie Dai; Nan Chen; Qiang Wang; Heng Zheng; Xiuli Zhang; Shiru Jia; Lilong Dong; Dacheng Feng
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.